Introduction
Seizure frequency has long been the primary metric in epilepsy research; however, frequency alone often fails to capture the profound impact of individual events on a patient’s life. To address this, the Revised Liverpool Seizure Severity Scale (LSSS) was developed as a specialized patient-reported outcome measure (PROM). Originally created by Baker et al. in 1991, the instrument underwent a significant revision in 1998 to enhance its psychometric sensitivity and structural clarity. With over 135 citations in scientific literature, the Revised LSSS stands as a highly reliable and valid instrument for assessing the multifaceted nature of seizure severity.
This article examines the Revised LSSS structure, scoring options, clinical applications, and practical value. Furthermore, it equips researchers and clinicians with actionable insights that improve epilepsy assessment and patient care.
Key Features of the Revised Liverpool Seizure Severity Scale (LSSS)
Purpose and Use
The Revised LSSS primarily assesses seizure severity through patient-reported ictal and post-ictal effects plus perceived control over seizures. Thus, it complements simple frequency counts and delivers a more complete picture of epilepsy impact. Clinicians and researchers therefore gain insights into how seizures affect daily life and treatment response.
Target Population
The Revised LSSS is validated for adolescents and adults aged 15 years and older, including:
- Adolescents (13–17 years)
- Young adults (18–24 years)
- Middle-aged adults (25–44 years)
- Older adults (45–64 years)
- Seniors (65+ years)
It specifically targets patients with epilepsy who experience recurrent partial or generalized seizures and can complete a self-report questionnaire.
Structure
The questionnaire consists of 20 items designed to evaluate the physical and psychological manifestations of epilepsy. Consequently, the coverage is broad, encompassing several critical domains:
- Predictability: Assessment of seizure warning symptoms or auras.
- Control: Evaluation of the patient’s perceived control over their seizures.
- Ictal Manifestations: Observations of what happens during the seizure, including loss of consciousness and physical effects.
- Post-ictal Recovery: Symptoms following the event and the time required for full recovery.
- Safety: Analysis of seizure-related injuries.
Therefore, the scale provides a comprehensive view of each patient’s experience.
Scoring Method
Each item uses ordinal Likert-type responses (typically 1–4), with some offering an additional 0 option. Researchers sum responses to produce two subscale scores:
- Perception of seizure control (Percept scale): range 7–32
- Ictal and post-ictal seizure effects: range 10–48
Higher scores indicate greater severity.
Additionally, the revised LSSS v2.0 scoring Proposed by Scott-Lennox et al. (2001), this method uses 12 ictal items to produce a single “most severe seizure” score. This score is linearly transformed to a 0–100 scale, where 100 represents maximum severity.
Administration Format
Patients complete the Revised LSSS quickly in 5–10 minutes. Furthermore, it supports flexible delivery:
- Paper-based
- Digital (online)
- In-person interview
- Phone or video call
Additionally, the Revised LSSS is a self-administered questionnaire making it ideal for busy clinics and large-scale studies.
Applications of the Revised Liverpool Seizure Severity Scale (LSSS)
Researchers and clinicians apply the Revised LSS across several key areas:
- Treatment planning: to tailor therapies based on patient-perceived burden
- Research endpoint: as a validated outcome measure in clinical trials and observational studies
Thus, the scale enhances both individual care and scientific understanding of epilepsy.
Languages and availability
The Revised LSSS is available in:
- English
- Mandarin Chinese
Additionally, it has been translated into several languages, although not all versions have formal validation.
Reliability and Validity
The Revised LSSS is considered a highly reliable and valid tool. For instance, the Ictal/Post-ictal subscale demonstrates a strong Cronbach’s alpha of 0.85, while the Perception of Control subscale maintains a coefficient of 0.69. Because of its robust psychometric properties, the scale is frequently utilized as a research endpoint in clinical trials.
Researchers can access key validation data through the following studies:
Limitations and Considerations
Despite its strengths, the Revised LSSS presents a few limitations:
- Self-report: As a patient-reported measure, it may be subject to social desirability bias or subjective interpretation.
- Language Barriers: While translated, not all versions have been formally validated in published literature.
- Social desirability bias: Patients may under-report severity to appear more controlled
Nevertheless, its focused design and strong psychometrics outweigh these considerations in most epilepsy settings.
Other Versions And Related Questionnaires
The Revised LSSS has evolved over time:
- Original LSSS (1991): the original 1991 version laid the foundation
- Revised LSSS (1998): improved item clarity and response options
- LSSS 2.0 (2001 scoring system): scoring system to produce a standardized 0–100 severity score.
Clinicians frequently use the Revised LSSS alongside complementary tools, such as:
- The National Hospital Seizure Severity Scale (NHS3)
- The Seizure Severity Questionnaire (SSQ).
Additional Resources
- The Original Validation Study link
- You can access the questionnaire as a PDF through this link (included within the 1998 publication)
- For inquiries, contact Prof. Gus A. Baker at g.a.baker@liverpool.ac.uk
- For additional LSSS resources, consult the Liverpool Epilepsy Research Group.
Frequently Asked Questions (FAQ)
- Who can use the Revised LSSS?
Clinicians, researchers, and healthcare providers use the Revised LSSS for adolescents and adults (aged 15 and older) who have epilepsy and experience recurrent seizures. - How long does it take to complete the Revised LSSS?
Patients typically finish the Revised LSSS in 5 to 10 minutes, which makes it highly practical for clinical and research settings. - How is the Revised LSSS administered?
Healthcare teams administer the questionnaire via paper, digital platforms, in-person interviews, or phone/video calls—offering flexibility across environments. - Is there any cost to using the Revised LSSS?
The Revised LSSS requires permission for commercial or funded academic use. Researchers should contact the developers for non-commercial clinical and research applications.
A Word From ResRef about the Revised Liverpool Seizure Severity Scale (LSSS)
The Revised Liverpool Seizure Severity Scale (LSSS) provides a structured patient-reported approach to assessing seizure severity beyond seizure frequency alone. By capturing ictal and post-ictal effects as well as patients’ perceived control over seizures, the instrument offers a useful complementary measure for epilepsy research and clinical evaluation.
References
- G A Baker, D F Smith, A Jacoby, J A Hayes, D W Chadwick, Liverpool Seizure Severity Scale revisited, Seizure, Volume 7, Issue 3, June 1998, Pages 201–205, Link
- S Rapp, S Shumaker, T Smith, P Gibson, R Berzon, R Hoffman, Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients, Quality of Life Research, Volume 7, Issue 4, May 1998, Pages 353–363, Link
- L Gao, L Xia, S Q Pan, T Xiong, S C Li, Psychometric properties of Chinese language Liverpool Seizure Severity Scale 2.0 (LSSS 2.0) and determinants of seizure severity for patients with epilepsy in China, Epilepsy & Behavior, Volume 31, February 2014, Pages 94–100, Link
- G A Baker, D F Smith, D B Smith, The development of a seizure severity scale as an outcome measure in epilepsy, Epilepsy Research, Volume 5, Issue 1, 1991, Pages 1–6, Link
- J Scott-Lennox, L Bryant-Comstock, R Lennox, G A Baker, Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale, Epilepsy Research, Volume 44, Issue 1, April 2001, Pages 53–63, Link
- M F O’Donoghue, M J Duncan, J W Sander, The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale, Epilepsia, Volume 37, Issue 6, June 1996, Pages 563–571, Link
- J A Cramer, B French, Development of a new seizure severity questionnaire: initial reliability and validity testing, Epilepsy Research, Volume 48, Issue 3, February 2002, Pages 187–197, Link
